USRE49035EActiveUtilityPatentIndex 60

Traditional Chinese medicine composition, and preparation and application thereof

Assignee: TASLY PHARMACEUTICAL GROUP COPriority: Jul 11, 2013Filed: Jul 11, 2014Granted: Apr 19, 2022

Est. expiryJul 11, 2033(~7 yrs left)· nominal 20-yr term from priority

Inventors:YAN XIJUN WU NAIFENG YAN KAIJING YE ZHENGLIANG ZHANG SHUNNAN ZHOU LIHONG ZHANG WENSHENG DONG HAI'OU

A61K 31/192A61K 9/19A61K 31/11A61K 36/82A61K 9/2068A61K 9/2018A61K 31/216A61K 9/1664A61K 36/537A61K 31/343A61K 9/16A61K 9/2009A61K 9/20A61K 31/045A61K 9/2059A61K 9/4866A61K 9/2031A61K 9/28A61K 9/2893A61K 9/2013A61K 31/704A61P 9/10A61K 36/258A61P 7/02A61P 9/00A61K 2300/00

PatentIndex Score

Cited by

128

References

Claims

Abstract

A traditional Chinese medicine composition for treating cardiovascular disease, and a preparation thereof, particularly a micro drop pill preparation thereof, and a method for preparing the preparation; the method for preparing the micro drop pill preparation can be used to prepare drop pills, coated drop pills, and drop pill capsules with a high drug loading capacity.

Claims

exact text as granted — not AI-modified

What is claimed is: 
     
       1. A Chinese medicine composition consisting of the following materials by weight percentage: 50.0%˜99.9% of Salvia Miltiorrhiza and Panax Notoginseng extract and 0.1%˜50.0% of borneol, wherein the Salvia Miltiorrhiza and Panax Notoginseng extract comprises the following ingredients by weight percentage:
 Danshensu:Salvianolic acid T:protocatechuic aldehyde: Salvianolic acid D:rosmarinic acid:Salvianolic acid B:Salvianolic acid A:Panax Notoginseng Saponin R1:Ginsenoside Rg1:Ginsenoside Re:Ginsenoside Rb1:Ginsenoside Rd:dihydrotanshinone I:tanshinone I:cryptotanshinone:tanshinone IIA=(2˜6):(0.5˜2): (1˜3):(0.2˜1):(0.2˜1):(0.5˜2):(0.5˜2):(0.2˜1):(1˜4): (0.1˜0.5):(1˜4):(0.1˜1):(0.01˜0.05):(0.05˜0.1): (0.02˜0.1):(0.1˜0.5). 
 
     
     
       2. The Chinese medicine composition according to  claim 1 , wherein said Chinese medicine composition consists of the following materials by weight percentage: 75.0%˜99.9% of Salvia Miltiorrhiza and Panax Notoginseng extract and 0.1%˜25.0% of borneol. 
     
     
       3. The Chinese medicine composition according to  claim 1 , wherein said traditional Chinese medicine composition is composed of the following materials by weight percentage: 90.0%˜99.9% of Salvia Miltiorrhiza and Panax Notoginseng extract and 0.1%˜10.0% of borneol. 
     
     
       4. The Chinese medicine composition according to  claim 1 , wherein the Salvia Miltiorrhiza and Panax Notoginseng extract comprises the following ingredients by weight parts:
 Danshensu:Salvianolic acid T:protocatechuic aldehyde: Salvianolic acid D:rosmarinic acid:Salvianolic acid B:Salvianolic acid A:Panax Notoginseng Saponin R1: Ginsenoside Rg1:Ginsenoside Re:Ginsenoside Rb1:Ginsenoside Rd:dihydrotanshinone I:tanshinone I:cryptotanshinone:tanshinone IIA=(3˜4):(0.9˜1.2): (1.4˜2.0):(0.5˜0.7):(0.5˜0.9):(1˜1.6):(0.7˜1.2): (0.5˜0.9):(1.8˜2.8):(0.2˜0.4):(1.7˜2.2):(0.2˜0.6): (0.03˜0.04):(0.07˜0.08):(0.05˜0.06):(0.26˜0.28). 
 
     
     
       5. The Chinese medicine composition according to  claim 4 , wherein the Salvia Miltiorrhiza and Panax Notoginseng extract comprises the following ingredients by weight parts:
 Danshensu:Salvianolic acid T:protocatechuic aldehyde: Salvianolic acid D:rosmarinic acid:Salvianolic acid B:Salvianolic acid A:Panax Notoginseng Saponin R1: Ginsenoside Rg1:Ginsenoside Re:Ginsenoside Rb1:Ginsenoside Rd:dihydrotanshinone I:tanshinone I: cryptotanshinone: tanshinone IIA=3.6:1.1:1.7:0.6:0.7:1.3:0.9:0.7:2.4:0.3:1.8:0.4:0.03:0.07:0.06:0.27. 
 
     
     
       6. The Chinese medicine composition according to  claim 1 , wherein the Salvia Miltiorrhiza and Panax Notoginseng extract is prepared with the following crude medicine by weight parts: Salvia Miltiorrhiza 75˜90 parts and Panax Notoginseng 10˜25 parts. 
     
     
       7. The Chinese medicine composition according to  claim 6 , wherein the Salvia Miltiorrhiza and Panax Notoginseng extract is prepared with the following crude medicine by weight parts: Salvia Miltiorrhiza 82˜84 parts, Panax Notoginseng 16˜17 parts. 
     
     
       8. A pharmaceutical preparation comprising the Chinese medicine composition according to  claim 1  and pharmaceutically acceptable carriers. 
     
     
       9. The pharmaceutical preparation according to  claim 8 , wherein said pharmaceutical preparation is in a dosage form of drop pill or micro drop pill, wherein said micro drop pill is prepared with the Chinese medicine composition and drop pill matrix in a ratio of 1:5˜5:1 by weight. 
     
     
       10. The pharmaceutical preparation according to  claim 9 , wherein said pharmaceutical preparation is a compound Salvia micro drop pill. 
     
     
       11. The Chinese medicine composition according to claim 4, wherein said traditional Chinese medicine composition is composed of the following materials by weight percentage: 90.0%˜9.9% of Salvia Miltiorrhiza and Panax Notoginseng extract and 0.1%˜10.0% of borneol.  
     
     
       12. The Chinese medicine composition according to claim 4, wherein the Salvia Miltiorrhiza and Panax Notoginseng extract is prepared with the following crude medicine by weight parts: Salvia Miltiorrhiza 75-90 parts and Panax Notoginseng 10-25 parts.  
     
     
       13. A pharmaceutical preparation comprising the Chinese medicine composition according to claim 4 and pharmaceutically acceptable carriers.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.